关注
Normi Gajjar
Normi Gajjar
Student
在 lmcp.ac.in 的电子邮件经过验证
标题
引用次数
引用次数
年份
In search of RdRp and Mpro inhibitors against SARS CoV-2: Molecular docking, molecular dynamic simulations and ADMET analysis
ND Gajjar, TM Dhameliya, GB Shah
Journal of molecular structure 1239, 130488, 2021
662021
In search of SARS CoV-2 replication inhibitors: virtual screening, molecular dynamics simulations and ADMET analysis
PR Nagar, ND Gajjar, TM Dhameliya
Journal of Molecular Structure 1246, 131190, 2021
532021
Darunavir ethanolate: Repurposing an anti-HIV drug in COVID-19 treatment
VP Chavda, N Gajjar, N Shah, DJ Dave
European Journal of Medicinal Chemistry Reports 3, 100013, 2021
482021
Recent advancements in applications of ionic liquids in synthetic construction of heterocyclic scaffolds: A spotlight
TM Dhameliya, PR Nagar, KA Bhakhar, HR Jivani, BJ Shah, KM Patel, ...
Journal of Molecular Liquids 348, 118329, 2022
432022
2-Deoxy-D-Glucose and its derivatives for the COVID-19 treatment: an update
Z Huang, VP Chavda, LK Vora, N Gajjar, V Apostolopoulos, N Shah, ...
Frontiers in pharmacology 13, 899633, 2022
302022
Recent advancements and developments in search of anti-tuberculosis agents: a quinquennial update and future directions
TM Dhameliya, KA Bhakhar, ND Gajjar, KA Patel, AA Devani, RV Hirani
Journal of Molecular Structure 1248, 131473, 2022
292022
Identification of anti-mycobacterial agents against mmpL3: virtual screening, ADMET analysis and MD simulations
KA Bhakhar, ND Gajjar, KB Bodiwala, DK Sureja, TM Dhameliya
Journal of Molecular Structure 1244, 130941, 2021
272021
Systematic virtual screening in search of SARS CoV-2 inhibitors against spike glycoprotein: pharmacophore screening, molecular docking, ADMET analysis and MD simulations
TM Dhameliya, PR Nagar, ND Gajjar
Molecular diversity 26 (5), 2775-2792, 2022
162022
Indole‐2‐carboxamides as New Anti‐Mycobacterial Agents: Design, Synthesis, Biological Evaluation and Molecular Modeling against mmpL3
KA Bhakhar, PV Vaghela, SD Varakala, SJ Chudasma, ND Gajjar, ...
ChemistrySelect 7 (26), e202201813, 2022
92022
In‐silico Computational Investigations of AntiViral Lignan Derivatives as Potent Inhibitors of SARS CoV‐2
DK Sureja, AP Shah, ND Gajjar, SB Jadeja, KB Bodiwala, TM Dhameliya
ChemistrySelect 7 (28), e202202069, 2022
72022
Recent Trends in Metal Nanoparticles (MNPs) Catalyzed Synthesis of Aza-and Oxa-Heterocycles
TM Dhameliya, RJ Patel, ND Gajjar, RH Amin, KB Bodiwala, DK Sureja
Advanced Nanocatalysis for Organic Synthesis and Electroanalyses, Ed Vijai K …, 2022
52022
In silico screening, ADMET analysis and MD simulations of phytochemicals of Onosma bracteata Wall. as SARS CoV-2 inhibitors
UG Vegad, ND Gajjar, PR Nagar, SP Chauhan, DJ Pandya, ...
3 Biotech 13 (7), 221, 2023
32023
Prevalence of CYP2C9 and CYP2C19 variants and the impact on clopidogrel efficacy in patients having CYPC19* 2 variant
MP Mehta, ND Gajjar, RJ Patel, LP Joshi, GB Shah
Indian journal of pharmacology 55 (1), 27-33, 2023
22023
Indole-2-carboxamides as New Anti-Mycobacterial Agents: Design, Synthesis, Biological Evaluation and Molecular Modeling Against mmpL3.
TM Dhameliya, KA Bhakhar, PV Vaghela, SD Varakala, SJ Chudasma, ...
Malaysian Journal of Medicine & Health Sciences 20, 2024
2024
2-Deoxy-D-Glucose and its Derivatives for the COVID-19 Treatment: An Update. Front. Pharmacol. 13: 899633. doi: 10.3389/fphar. 2022.899633
Z Huang, VP Chavda, LK Vora, N Gajjar, V Apostolopoulos, N Shah, ...
Frontiers in Pharmacology| www. frontiersin. org 13, 2022
2022
系统目前无法执行此操作,请稍后再试。
文章 1–15